This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Patrick E. McBride, MD, MPH

JAMA. 2007;298:336-338.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Evidence that elevated serum triglyceride levels are associated with increased risk for atherosclerotic events is increasing. In this issue of JAMA, 2 large, long-term prospective cohort studies conducted in different populations by Bansal and colleagues¹ and by Nordestgaard and colleagues² support the role of nonfasting triglyceride levels as a significant risk factor for coronary heart disease (CHD) events. However, a high serum triglyceride level is associated with abnormal lipoprotein metabolism, as well as with other CHD risk factors including obesity, insulin resistance, diabetes mellitus, and lowered levels of high-density lipoprotein cholesterol (HDL-C).³ When determining CHD risk, how important is it to know which came first—high serum triglyceride levels or the risk factors that cause high levels?

Elevated triglyceride levels have a substantial effect on lipoprotein metabolism, which explains much of the controversy about the role of serum triglycerides as a risk factor for CHD.⁴ . . . [Full Text of this Article]

Author Affiliations: Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.

RELATED ARTICLES

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
Børge G. Nordestgaard, Marianne Benn, Peter Schnohr, and Anne Tybjærg-Hansen
JAMA. 2007;298(3):299-308.
ABSTRACT | FULL TEXT  

Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
Sandeep Bansal, Julie E. Buring, Nader Rifai, Samia Mora, Frank M. Sacks, and Paul M Ridker
JAMA. 2007;298(3):309-316.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Divergent Associations of Plasma Choline and Betaine with Components of Metabolic Syndrome in Middle Age and Elderly Men and Women
Konstantinova et al.
J. Nutr. 2008;138:914-920.
ABSTRACT | FULL TEXT  

Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease
Ntyintyane et al.
QJM 2008;101:111-119.
ABSTRACT | FULL TEXT  

Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Ridker
Clin. Chem. 2008;54:11-13.
FULL TEXT  

Are Nonfasting Better Than Fasting Triglyceride Levels at Predicting Cardiac Events?
Journal Watch Cardiology 2007;2007:1-1.
FULL TEXT